March 11, 2009
Pathfinder Hires Medical Device Veteran as CEO
Company Enters Commercial Phase with Product Launch at the American Hepato-Pancreato Billary Association (AHPBA) Conference
“We conducted an exhaustive, nationwide search to find the best leader for Pathfinder,” said Clay B. Thorp, General Partner, Hatteras Venture Partners and Chair of the Board and search http://laparkan.com/buy-vardenafil/ committee for Pathfinder. “Skip brought the right blend of experience, character, and vision. Having led sales in highly successful companies in our field, we felt he was ready to take his skills to the next level as CEO of Pathfinder.”
“I am thrilled with the opportunity to lead Pathfinder,” said Skip Goode, President and CEO of Pathfinder. “The engineering and scientific teams have done a terrific job of designing, building, and gaining FDA clearance for the first system for surgical planning and intra-operative navigation of liver surgery. Now, we have a great opportunity to introduce these systems to hospitals across the country. Pathfinder’s ability to increase the number of operable liver cancers and improve the confidence of liver surgeons has the potential to save lives and drive significant economic benefits for health care.”
“We conducted an exhaustive, nationwide search to find the best leader for Pathfinder,” said Clay B. Thorp, General Partner, Hatteras Venture Partners and Chair of the Board and search http://laparkan.com/buy-vardenafil/ committee for Pathfinder. “Skip brought the right blend of experience, character, and vision. Having led sales in highly successful companies in our field, we felt he was ready to take his skills to the next level as CEO of Pathfinder.”
“I am thrilled with the opportunity to lead Pathfinder,” said Skip Goode, President and CEO of Pathfinder. “The engineering and scientific teams have done a terrific job of designing, building, and gaining FDA clearance for the first system for surgical planning and intra-operative navigation of liver surgery. Now, we have a great opportunity to introduce these systems to hospitals across the country. Pathfinder’s ability to increase the number of operable liver cancers and improve the confidence of liver surgeons has the potential to save lives and drive significant economic benefits for health care.”
BACK TO NEWS